1.Sales and profit
See section β- Genworth Financial Inc had $7.3B of revenue in fiscal 2025, up 0.1% on the year before. Over five years, revenue changed β2.5% a year on average.
- Genworth Financial Inc made $223M of net profit in fiscal 2025.
GNW NYSE Life Insurance Financials FY2016βFY2025
Genworth Financial Inc had $7.3B of revenue in fiscal 2025, up 0.1% on the year before. Over five years, revenue changed β2.5% a year on average.
Last close Β· Oct 27, 2026
$8.89
+$0.47 (+5.58%) past year
Hi! I read Genworth Financial Incβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+0.1%
Only a little. Sales grew 0.1% last year.
Does it make a profit?
3.1%
A little. It keeps 3.1% of every sale as profit.
How healthy are the accounts?
5 / 7
Mixed. It passes 5 of 7 health tests.
How is the share priced?
16.8x
One share costs 16.8 times its yearly profit per share.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA summarises the numbers
Genworth Financial Inc had $7.3B of revenue in fiscal 2025, up 0.1% on the year before.
Over five years, revenue changed β2.5% a year on average.
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Loss periods are shown in red.
KIRA summarises the numbers
Genworth Financial Inc made $223M of net profit in fiscal 2025.
Net income
Net income
Diluted EPS
Diluted EPS
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
KIRA summarises the numbers
Genworth Financial Inc returned $247M to shareholders in fiscal 2025.
The diluted share count fell 5.8%.
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
KIRA summarises the numbers
In the last 12 months, insiders sold $3.7M of shares on the open market and bought none.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$3.7M
4 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Thomas J McInerneyPresident and CEO; Director, Director | Sold | 100,000 | $10.53 | $1.1M | Form 4 |
| Aug 24, 2026 | Melissa HagermanEVP and Chief HR Officer | Sold | 14,708 | $9.92 | $0.1M | Form 4 |
| Aug 21, 2026 | Gregory S. KarawanEVP and General Counsel | Sold | 40,000 | $9.91 | $0.4M | Form 4 |
| May 22, 2026 | Robert P Restrepo JrDirector | Sold | 50,000 | $9.12 | $0.5M | Form 4 |
| May 22, 2026 | Thomas J McInerneyPresident and CEO; Director, Director | Sold | 100,000 | $9.27 | $0.9M | Form 4 |
| Dec 2, 2025 | Thomas J McInerneyPresident and CEO; Director, Director | Sold | 40,000 | $8.64 | $0.3M | Form 4 |
| Nov 24, 2025 | Gregory S. KarawanEVP and General Counsel | Sold | 40,000 | $8.51 | $0.3M | Form 4 |
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Genworth Financial Inc can carry it.
KIRA summarises the numbers
Genworth Financial Inc has $523M more cash than debt.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.6B | $1.8B | $2.2B | $2.0B | $2.0B |
| Debt incl. finance leases | $1.9B | $1.6B | $1.6B | $1.5B | $1.5B |
| Net debt / EBITDA | 0.4x | β0.2x | β2.1x | β | β |
| Debt / equity | 0.1x | 0.2x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 3.0x | 7.7x | 0.3x | β | β |
| Total assets | $99.2B | $89.7B | $90.8B | $86.8B | $88.1B |
| Total liabilities | $82.9B | $81.3B | $82.5B | $77.4B | $78.3B |
| Shareholders' equity | $15.5B | $7.6B | $7.5B | $8.4B | $8.8B |
| Net debt (β = net cash) | $328M | β$188M | β$631M | β$530M | β$523M |
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Return on capital, equity and assets (annual)
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
KIRA summarises the numbers
Genworth Financial Inc passes 5 of 7 financial health tests (Piotroski F-score).
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 7 | 6 / 7 | 5 / 7 | 5 / 7 | 5 / 7 | 7 / 7 | 5 / 7 | 5 / 7 | 5 / 7 |
| Accruals ratio | β2.1% | β1.7% | β1.5% | β1.7% | β1.7% | 0.4% | β0.1% | β0.6% | 0.2% | β0.1% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $8.4B | $7.5B | $7.9B | $7.7B | $8.3B | $7.8B | $7.5B | $7.5B | $7.3B | $7.3B |
| Provision for credit losses | β | β | $0.0M | β | β | β | β | β | β | β |
| Operating income | β$316M | $530M | β$5.0M | $355M | $310M | $474M | $818M | $41.0M | β | β |
| Interest expense | $337M | $266M | $256M | $231M | $195M | $160M | $106M | $118M | $115M | $105M |
| Pretax income | $320M | $127M | $137M | $521M | $928M | $1.1B | $1.4B | $303M | $595M | $433M |
| Income tax | $358M | β$406M | $70.0M | $139M | $230M | $248M | $319M | $104M | $158M | $84.0M |
| Net income | β$277M | $817M | $119M | $343M | $178M | $850M | $916M | $76.0M | $299M | $223M |
| Diluted EPS | β$0.56 | $1.63 | $0.24 | $0.67 | $0.35 | $1.65 | $1.79 | $0.16 | $0.68 | $0.54 |
| Diluted shares | 0.50B | 0.50B | 0.50B | 0.51B | 0.51B | 0.51B | 0.51B | 0.47B | 0.44B | 0.41B |
| Cash flow | ||||||||||
| Cash from operations | $1.9B | $2.6B | $1.6B | $2.1B | $2.0B | $437M | $1.0B | $597M | $88.0M | $327M |
| Depreciation and amortization | $498M | $392M | $348M | $408M | $463M | $384M | $326M | $264M | $249M | $231M |
| Stock-based compensation | $32.0M | $31.0M | $35.0M | $26.0M | $39.0M | $40.0M | $37.0M | $49.0M | $51.0M | $58.0M |
| Acquisitions | $0.0M | $5.0M | $0.0M | $0.0M | β | β | β | β | β | β |
| Share buybacks | β | β | β | β | $0.0M | $0.0M | $64.0M | $296M | $189M | $247M |
| Dividends and buybacks | β | β | β | β | $0.0M | $0.0M | $64.0M | $296M | $189M | $247M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $2.8B | $2.9B | $2.0B | $3.3B | $1.0B | $1.6B | $1.8B | $2.2B | $2.0B | $2.0B |
| Total debt | $4.2B | $4.2B | $3.7B | $3.3B | $3.4B | $1.9B | $1.6B | $1.6B | $1.5B | $1.5B |
| Goodwill | $14.0M | β | β | β | β | β | β | β | β | β |
| Intangible assets | β | β | β | β | $157M | $143M | $203M | $198M | $197M | β |
| Total assets | $104.7B | $105.3B | $100.9B | $101.3B | $105.7B | $99.2B | $89.7B | $90.8B | $86.8B | $88.1B |
| Total liabilities | $90.2B | $90.0B | $86.7B | $86.7B | $89.9B | $82.9B | $81.3B | $82.5B | $77.4B | $78.3B |
| Shareholders' equity | $12.6B | $13.4B | $12.5B | $14.2B | $15.3B | $15.5B | $7.6B | $7.5B | $8.4B | $8.8B |
| Margins | ||||||||||
| Operating margin | β3.8% | 7.1% | β0.1% | 4.6% | 3.7% | 6.1% | 10.9% | 0.5% | β | β |
| EBITDA margin | 2.2% | 12.3% | 4.3% | 9.9% | 9.3% | 11.0% | 15.3% | 4.1% | β | β |
| Net margin | β3.3% | 10.9% | 1.5% | 4.5% | 2.1% | 10.9% | 12.2% | 1.0% | 4.1% | 3.1% |
| Returns | ||||||||||
| Return on capital | β1.5% | 3.6% | β0.0% | 1.8% | 1.3% | 2.3% | 8.4% | 0.4% | β | β |
| Return on equity | β2.2% | 6.3% | 0.9% | 2.6% | 1.2% | 5.5% | 7.9% | 1.0% | 3.8% | 2.6% |
| Return on assets | β0.3% | 0.8% | 0.1% | 0.3% | 0.2% | 0.8% | 1.0% | 0.1% | 0.3% | 0.3% |
| Return on tangible equity | β2.2% | 6.1% | 1.0% | 2.4% | 1.2% | 5.5% | 12.3% | 1.0% | 3.6% | 2.5% |
| Growth | ||||||||||
| Revenue growth | β | β10.2% | 5.2% | β2.5% | 7.5% | β5.6% | β4.2% | β0.1% | β2.6% | 0.1% |
| Net income growth | β | β | β85.4% | 188.2% | β48.1% | 377.5% | 7.8% | β91.7% | 293.4% | β25.4% |
| EPS growth | β | β | β85.3% | 179.2% | β47.8% | 371.4% | 8.5% | β91.1% | 325.0% | β20.6% |
| Share count change | β | 0.6% | β0.2% | 1.9% | 0.4% | 0.6% | β0.7% | β7.0% | β7.5% | β5.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | 7.7x | 1.5x | 5.1x | 0.0x | 3.1x | 0.4x | β0.2x | β2.1x | β | β |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.2x | 0.2x | 0.1x | 0.2x | 0.2x | 0.2x | 0.2x |
| Interest coverage | β0.9x | 2.0x | β0.0x | 1.5x | 1.6x | 3.0x | 7.7x | 0.3x | β | β |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.4% | 0.4% | 0.4% | 0.3% | 0.5% | 0.5% | 0.5% | 0.7% | 0.7% | 0.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 6.0 | 5.0 | 5.0 | 5.0 | 7.0 | 5.0 | 5.0 | 5.0 |
| Accruals ratio | β2.1% | β1.7% | β1.5% | β1.7% | β1.7% | 0.4% | β0.1% | β0.6% | 0.2% | β0.1% |
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
Source: SEC EDGAR XBRL filings (CIK 0001276520). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.